Skip to content
Clinical Research Made Simple

Clinical Research Made Simple

Trusted Resource for Clinical Trials, Protocols & Progress

Tag: oncology

Examples of Parallel Designs in Oncology Trials – Clinical Trial Design and Protocol Development

Posted on June 12, 2025 digi By digi

Examples of Parallel Designs in Oncology Trials – Clinical Trial Design and Protocol Development “Parallel Design Examples in Cancer Research Trials” Introduction to Oncology Trials Oncology clinical trials aim to discover and evaluate new treatment methods for cancer. These trials are essential for the development of new therapies, and they also provide patients with access…

Read More “Examples of Parallel Designs in Oncology Trials – Clinical Trial Design and Protocol Development” »

Clinical Trial Design and Protocol Development, Parallel Group Designs

Master Protocols and Platform Trials in Oncology – Clinical Trial Design and Protocol Development

Posted on June 4, 2025 digi By digi

Master Protocols and Platform Trials in Oncology – Clinical Trial Design and Protocol Development “Understanding Master Protocols and Platform Trials in Cancer Treatment” Introduction to Master Protocols and Platform Trials in Oncology Oncology, a critical branch of medicine dealing with cancer, has seen significant advancements over the years. One of these advancements is the development…

Read More “Master Protocols and Platform Trials in Oncology – Clinical Trial Design and Protocol Development” »

Adaptive Trial Designs, Clinical Trial Design and Protocol Development

Quick Guide

  • Clinical Trial Phases
    • Preclinical Studies
    • Phase 0 (Microdosing Studies)
    • Phase 1 (Safety and Dosage)
    • Phase 2 (Efficacy and Side Effects)
    • Phase 3 (Confirmation and Monitoring)
    • Phase 4 (Post-Marketing Surveillance)
  • Regulatory Guidelines
    • U.S. FDA Regulations
    • CDSCO (India) Guidelines
    • EMA (European Medicines Agency) Guidelines
    • PMDA (Japan) Guidelines
    • MHRA (UK) Guidelines
    • TGA (Australia) Guidelines
    • Health Canada Guidelines
    • WHO Guidelines
    • ICH Guidelines
    • ASEAN Guidelines
  • Clinical Trial Design and Protocol Development
    • Randomized Controlled Trials (RCTs)
    • Adaptive Trial Designs
    • Crossover Trials
    • Parallel Group Designs
    • Factorial Designs
    • Cluster Randomized Trials
    • Single-Arm Trials
    • Open-Label Studies
    • Blinded Studies (Single, Double, Triple)
    • Non-Inferiority and Equivalence Trials
    • Randomization Techniques in Crossover Trials
  • Good Clinical Practice (GCP) and Compliance
    • GCP Training Programs
    • ICH-GCP Compliance
    • GCP Violations and Audit Responses
    • Monitoring Plans
    • Investigator Responsibilities
    • Sponsor Responsibilities
    • Ethics Committee Roles

Menu

Recent Posts

  • Examples of Parallel Designs in Oncology Trials – Clinical Trial Design and Protocol Development
  • Impact of Cultural and Linguistic Validation in Multinational Phase 3 Trials: Ensuring Data Quality and Global Compliance
  • Phase 1 Study Designs for Cell and Gene Therapies
  • Drug Utilization Studies and Physician Practice Patterns in Phase 4
  • Strategies for Managing High Screen Failure Rates in Phase 3 Trials: Practical Approaches to Optimize Enrollment

Copyright © 2025 Clinical Research Made Simple.

Powered by PressBook WordPress theme